Auriga is reiterating their Buy rating on McKesson (NYSE: MCK) after the recent acquisition of the U.S. Oncology (NASDAQ: USON) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE